title: Pan-HER inhibition in EGFR wild-type non-small-cell lung cancer.
authors.affiliation: Oncology Department, Av Bugnon 46, CHUV, 1011 Lausanne, Switzerland. Electronic address: solange.peters@chuv.ch.
authors.forename: Solange
authors.initials: S
authors.lastname: Peters
authors.affiliation: VU University Medical Center, Amsterdam, Netherlands.
authors.forename: Egbert
authors.initials: E
authors.lastname: Smit
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D000069347:Erlotinib Hydrochloride; D005260:Female; D006801:Humans; D008297:Male; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D016283:Proto-Oncogene Proteins p21(ras); D011799:Quinazolines / Q000008:administration & dosage*; D052999:Quinazolinones / Q000008:administration & dosage*; D018631:ras Proteins / Q000235:genetics*
chemical_list: C117307:KRAS protein, human; D047428:Protein Kinase Inhibitors; D011518:Proto-Oncogene Proteins; D011799:Quinazolines; D052999:Quinazolinones; C525726:dacomitinib; D000069347:Erlotinib Hydrochloride; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins